Latest news with #PunitSoni
Forbes
01-05-2025
- Business
- Forbes
Suki AI Is Healthcare's New Infrastructure
Doctor in a comfortable office using AI on laptop with infographics displayed Venture capital is making an aggressive bet on ambient AI. It's not just validation, it's fuel. Backers like Venrock and Breyer Capital have bet on Suki's ability to deliver not just innovation, but real operational leverage in clinical settings. Their investment underscores a belief that ambient AI isn't just a tech layer — it's a venture-scale opportunity to reshape healthcare delivery at its core. AI in healthcare has long overpromised and underdelivered, until now. While most tools have added more clicks and dashboards, ambient AI is subtracting: it subtracts friction, burnout, and time spent charting instead of caring. The national rollout of Athenahealth Ambient Notes powered by Suki isn't just a win for one startup, it's a signal that invisible, assistive AI is finally hitting its stride. And here's the thing: it's not just a workflow fix. It's a redefinition of what tech in healthcare should be: unseen, unfelt, but utterly indispensable. We've seen the same cycle play out again and again: a shiny new tech tool enters healthcare, dazzles in demos, and falls flat in practice. But ambient AI breaks the pattern. Instead of interrupting clinical workflows, it blends into them. That's what makes Athenahealth's decision to integrate Suki into Ambient Notes so consequential. What began as a beta that logged over 60,000 clinical encounters is now live across the company's vast network. Suki AI Platform 1 'This milestone with Athenahealth marks more than just scale. It signals real transformation for clinicians,' said Punit Soni, CEO and founder of Suki. 'By embedding Suki deeply into the EHR, we're delivering on the promise of ambient AI: less time on documentation, more time for care. This is what innovation should look like — seamless, intuitive, and focused entirely on the user experience.' Suki reports an adoption rate up to 2X that of competitors. The company says clinicians complete notes 72% faster, and physicians on the ground confirm the impact. 'I was used to spending 4 to 6 hours of my weekend catching up on documentation,' said Dr. Janelle Smith, a primary care physician in Springfield. 'Now, using Ambient Notes, I haven't been to the clinic on a single weekend in months, and I am close to 90-100 percent same-day note completion. It's really been transformative to my practice, as well as for my patient relationships, a true win-win.' Ambient AI isn't just saving time. It's saving careers. Athenahealth's own survey data found that nearly half of physicians pointed to documentation as the top area where AI could help. The product-market fit is undeniable. 'Across our network of ambulatory care providers, we are seeing rapid adoption of ambient listening technologies,' said Paul Brient, chief product officer at Athenahealth. 'It's clear this technology is well matched to solve one of the industry's biggest pain points—clinical documentation—and will only improve further through innovation and partnerships like this one with Suki.' Zoom is also betting on ambient AI. In late 2024, the company integrated Suki's note-taking into its telehealth platform, part of its broader productivity push via Zoom AI Companion. For healthcare customers operating under Business Associate Agreements (BAAs), the integration provides compliant documentation with minimal effort. Suki isn't just integrating, it's becoming the backend. According to a report by Definitive Healthcare, Zoom holds a 36.16% market share in telehealth — making it the most widely used vendor in the sector. The platform serves over 140,000 healthcare customers worldwide, including eight of the ten largest U.S. health systems and nine of the top ten hospitals, according to U.S. News rankings. Its dominant footprint makes it a powerful partner for scaling ambient AI into virtual care delivery. 'Suki continues to execute beautifully with a magical product for an ecosystem in desperate need of one,' said Bryan Roberts, partner at Venrock. 'Its ambient digital assistant for doctors makes use of the greatest technology wave in decades — AI — in a population that has all too often been left behind with regards to technology innovation — healthcare.' Suki has also secured partnerships with major electronic health records systems, including Epic, Cerner, and Meditec. VCs are pouring capital into ambient AI scribes with over $5.6 billion invested in the sector in 2024 alone. Abridge, Ambience Healthcare, Nabla, and Suki have all landed serious backing. Abridge leads with $462 million; Suki has raised $168 million; Ambience and Nabla follow at $100 million and $43 million, respectively. To VCs, this isn't a product race — it's an infrastructure bet. The winner in ambient AI will own the pipes through which modern medicine flows. Features come and go. Platforms endure. The company that captures the ambient layer captures the future of healthcare delivery. When it comes to building ambient AI platforms for healthcare, funding isn't just about speed — it's about survival, scale, and long-term defensibility. Here's why: In this category, funding isn't just fuel — it's a moat. Suki stands out in this crowded field because it's fully AI-powered. No human scribes. No offshoring. No lag. That gives it a scalability and margin advantage that other models can't easily match. Moreover, the company plans to deepen its current product offerings while developing new ones, including AI tools for healthcare staffing. Founded in 2017 by former Google and Flipkart exec Punit Soni, Suki has secured capital from Venrock, Breyer Capital, Zoom Ventures, and March Capital. But it's not just capital, it's conviction. Suki AI Founder Punit Singh Soni speaking at health tech conference HIMSS. 'With a large language model, you can get to a demo. But it takes years of work to make a great product that works at scale, in all languages, across large healthcare settings,' Soni said. Suki stands apart by combining a fully automated clinical AI assistant with a white-labeled platform that powers other telehealth and EHR companies, not just its own product. While competitors like Nuance and Abridge focus on large health systems and Ambience emphasizes platform breadth, Suki targets agile healthcare players with a lightweight, extensible product that combines ambient documentation with interactive voice commands thereby positioning itself as both a clinical assistant and an infrastructure layer for the future of healthcare interfaces. Additionally, Suki stands out with its relationships. Relationships are critical in healthcare AI since success relies on strong networks, not just for influence, but for performance. Partnerships give companies access to richer data, enabling them to train smarter models. More collaborators mean more feedback to improve accuracy, and deeper integration with EHR systems makes it easier to scale across clinical environments. Suki has established a robust network of partnerships across the healthcare and technology sectors, enhancing its AI-powered clinical assistant offerings. Key collaborations include: These partnerships underscore Suki's commitment to reducing administrative burdens for clinicians and improving patient care through advanced AI solutions. According to Precedence Research, the global AI in healthcare market is projected to hit $613.81 billion by 2034. Ambient AI is one of its fastest-growing segments. The prize is massive, and Suki is positioning itself as the infrastructure layer for this next generation. As the market expands, the question won't be 'does this tech work?' It will be 'Who do we trust to build it right?' Ambient AI isn't a niche feature. It's becoming the connective tissue of modern healthcare. For VCs, it's a rare convergence of scale, clinical demand, and stickiness. For doctors, it's relief. This moment isn't just a product launch. It's a shift in the power dynamic between AI and healthcare. And if Suki continues to execute, it could be the company that defines how AI is integrated into the exam room – not as a screen, but as a silent, trusted partner. The real question isn't if ambient AI will win. It's who will own it.
Yahoo
03-03-2025
- Business
- Yahoo
Wolters Kluwer and Suki to integrate UpToDate's trusted physician-authored content into Suki Assistant
Suki AI-powered ambient solution will include access to relevant UpToDate evidence-based content to help reduce the administrative burden for clinicians supporting better care for patients WALTHAM, Mass. & REDWOOD CITY, Calif., March 03, 2025--(BUSINESS WIRE)--Wolters Kluwer Health and Suki® are partnering to streamline administrative tasks for clinicians by making UpToDate®, a market-leading clinical decision support (CDS) solution, accessible from within Suki Assistant. Suki is a leader in healthcare AI that aims to make healthcare technology invisible and assistive so clinicians can focus on what's most important: their patients. Suki Assistant is an AI assistant that saves clinicians time and generates incremental revenue by automatically creating clinical notes ambiently, generating patient summaries, performing smart dictation, recommending codes to improve billing, and answering patient questions using data in the EHR. Beyond Suki Assistant, Suki's AI platform is used by many healthcare tech companies like Zoom, athenahealth, and others to power their AI experiences. Wolters Kluwer's UpToDate is one of the most trusted resources in healthcare, providing reliable clinical and drug information and evidence-based recommendations at the point of care. Clinicians using UpToDate will now have seamless access to clinical evidence directly within their Suki-generated notes—before, during, and after patient encounters. This integration empowers providers to make informed decisions at the point of care, reducing administrative burden and allowing them to focus more on meaningful patient interactions. This supports an improved experience for both clinicians and patients. "Clinicians rely on UpToDate to support their decision making and we are committed to ensuring they can access the content they need to help make the best decisions for each patient, wherever they are in the workflow. Through our partnership with Suki, we can help enrich clinical notes so clinicians can be more fully present with their patients," said Greg Samios, CEO Clinical Effectiveness for Wolters Kluwer Health. "We aim to continue to make Suki an ever-present, invisible assistant that not only streamlines clinical documentation, but also supports clinical reasoning for clinicians," said Punit Soni, CEO and Founder of Suki. "This partnership with Wolters Kluwer is a natural evolution of Suki's Q&A capability following our partnership with Google Cloud earlier this year. By integrating evidence-based clinical content from UpToDate, Suki empowers clinicians with reliable insights to support their decision-making and enhance treatment recommendations. This will over time be available both through Suki Assistant and Suki Platform." About Wolters Kluwer Wolters Kluwer (Euronext: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX, Euro Stoxx 50 and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY). For more information, visit follow us on LinkedIn, Facebook, YouTube and Instagram. Learn more about UpToDate here. About Suki Suki is a leading technology company that provides AI voice solutions for healthcare. Its mission is to reimagine the healthcare technology stack, making it invisible and assistive to lift the administrative burden from clinicians. Its flagship product is Suki Assistant, an AI assistant that uses generative AI to automatically create clinical documentation by ambiently listening to patient-clinician conversations. Suki helps clinicians complete notes 72% faster on average, assists with other tasks including coding and answering questions, and generates incremental revenue for organizations, delivering a 9X ROI in year 1. Suki also offers its proprietary AI and speech platform, Suki Platform, to partners who want to create best-in-class ambient and voice experiences for their solutions. Suki is backed by premier investors such as Venrock, First Round, Flare Capital Partners, March Capital, and Hedosophia. To learn more, visit or follow us on LinkedIn and Twitter. View source version on Contacts Media Contacts Suzanne MoranAssociate Director, External CommunicationsWolters Kluwer Health+1 Suki Media Contact pr@
